QCM
MDGL icon

Quantinno Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quantinno Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
2,542
+452
+22% +$232K ﹤0.01% 2310
2026
Q1 		$1.09M Buy
2,090
+1,726
+474% +$825K ﹤0.01% 2083
2025
Q4 		$212K Buy
+364
New +$186K ﹤0.01% 3029
2025
Q2 		– Sell
-2,644
Closed -$876K – 2611
2025
Q1 		$876K Buy
+2,644
New +$869K 0.01% 1195

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantinno Capital Management's MDGL Position: Q2 2026 in Review

Quantinno Capital Management increased its Madrigal Pharmaceuticals (MDGL) stake by 22% in Q2 2026, buying an estimated $232K and bringing the position to 2,542 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2310.

Quantinno Capital Management first reported a position in MDGL in Q1 2025 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Quantinno Capital Management held 2,542 shares of Madrigal Pharmaceuticals worth $1.36M as of Q2 2026.
  • Quantinno Capital Management bought 452 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $232K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2310 holding.
  • Quantinno Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.